Skip to main content
. Author manuscript; available in PMC: 2014 Oct 9.
Published in final edited form as: Br J Haematol. 2012 Jun 15;158(5):581–588. doi: 10.1111/j.1365-2141.2012.09186.x

Table 1.

Prognostic factors for complete remission

Elacytarabine treatment Control population
N=61 (%) N=594 (%)
Six prognostic factors for CR
    Duration of CR1 < 12 months 71 73
    Duration of CR2 < 6 months 100 85
    2nd salvage therapy (no stem cell transplantation) 100 85
    Non-inversion 16 AML 93 96
    Platelet count < 50 × 109/l 66 69
    Leucocytosis > 50 × 109/l 16 11
Risk groups (number of prognostic factors)
    Low (1-2) 2 8
    Intermediate 1 (3) 7 20
    Intermediate 2 (4) 39 38
    High (5-6) 52 33

CR, complete remission; CR1, first CR; CR2, second CR; AML, acute myeloid leukaemia.